Score Overview
Explore the 2021 public Archive ranking โ
Where Omnicell Inc has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 20 years of fundamentals. OMCL does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 33.87 | โ |
1 Year2025-09-26 | $ 30.72 | 10.25% |
5 Years2021-09-28 | $ 148.66 | -77.22% |
10 Years2016-09-28 | $ 38.10 | -11.10% |
20 Years2006-09-28 | $ 17.68 | 91.57% |
All Time2001-08-07 | $ 9.51 | 256.15% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | All Time2001-08-07 |
|---|---|---|---|---|---|---|
| Price | $ 33.87 | $ 30.72 | $ 148.66 | $ 38.10 | $ 17.68 | $ 9.51 |
| Return | โ | 10.25% | -77.22% | -11.10% | 91.57% | 256.15% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1.24B | $ 39M | $ 292M |
| 2025 | $ 1.18B | $ 2M | $ 196M |
| 2024 | $ 1.11B | $ 12M | $ 381M |
| 2023 | $ 1.14B | -$ 20M | $ 467M |
| 2022 | $ 1.29B | $ 5M | $ 341M |
| 2021 | $ 1.13B | $ 77M | $ 359M |
| 2020 | $ 892M | $ 32M | $ 496M |
| 2019 | $ 897M | $ 61M | $ 136M |
| 2018 | $ 787M | $ 37M | $ 67M |
| 2017 | $ 716M | $ 20M | $ 32M |
| 2016 | $ 692M | $ 603K | $ 54M |
| 2015 | $ 484M | $ 30M | $ 82M |
| 2014 | $ 440M | $ 30M | $ 125M |
| 2013 | $ 380M | $ 23M | $ 104M |
| 2012 | $ 314M | $ 16M | $ 62M |
| 2011 | $ 245M | $ 10M | $ 199M |
| 2010 | $ 222M | $ 4M | $ 183M |
| 2009 | $ 213M | $ 444K | $ 169M |
| 2008 | $ 251M | $ 12M | $ 120M |
| 2007 | $ 213M | $ 43M | $ 169M |
| 2006 | $ 154M | $ 10M | $ 60M |
| 2005 | $ 121M | -$ 2M | $ 29M |
| 2004 | $ 123M | $ 10M | $ 30M |
| 2003 | $ 102M | $ 7M | $ 33M |
| 2002 | $ 87M | -$ 5M | $ 21M |
| IPO2001 | $ 86M | -$ 1M | $ 23M |

Omnicell Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 484M to $ 1.18B and net income declined from $ 30M to $ 2M. Revenue increased in 7 of those 10 years; net income in 6.
Across Omnicell Inc's full reported history, from 2001 to 2025, revenue grew from $ 86M to $ 1.18B and net income went from -$ 1M to $ 2M. Revenue increased in 80% of the years measured; net income in 64%.
Omnicell Inc currently holds a 20-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.
Membership
Explore OMCL with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Neogen CorporationNEOGยท revenue grew in 90% of years
Fresenius Medical Care CorporationFMSยท revenue grew in 80% of years
Innoviva IncINVAยท revenue grew in 75% of years
Ligand Pharmaceuticals IncorporatedLGNDยท revenue grew in 75% of years
Bristol-Myers Squibb CompanyBMYยท revenue grew in 65% of years